4 Of Our 20 Portfolios Dropped More Than 20% In November - Here's Why

Cutout paper illustration representing scheme and Stocks inscription

Image Source: Pexels


Introduction

Of the 20 stock categories that I follow (see articles here), 4 declined in excess of 20% in November, another 3 by at least 10%, and 8 by lesser amounts, leaving only 5 categories that actually increased. This article highlights the performances of the 4 categories that declined in November, in descending order, and their constituents, and the reasons behind the category declines. 


The 4 Categories That Declined More Than 20%

  1. Pure-play Quantum Computing Stocks Portfolio:  DOWN 31.9% in November; UP 33.3% YTD
    • Constituent Returns: RGTI (-42,2%); QBTS (-38.8%); QUBT (-30.0%); IONQ (-21.1%) 
    • Reason(s) for Decline: Because investors:
      • reassessed their lofty valuations,
      • worried about dilution from repeated capital raises, 
      • reacted to skepticism about commercialization timelines, and
      • were concerned about the sector’s
        • speculative nature,
        • high R&D costs, and
        • comparisons to the much larger AI market which amplified the pullback.
    • Article of Interest:
  2. Pure-play Plant-based Food Stocks Portfolio: DOWN 26.8% in November; DOWN 23.5% YTD
    • Constituent Returns: GUROF (-19.9%); OTLY (-21.8%); BYND (-41.0); LSF (-44.6%)
    • Reason(s) for Decline:
      • Because of shrinking sales, cash burn, and consumer fatigue
  3. AI-focused Pure-play Drug Discovery Stocks Portfolio: DOWN 24.9% in November; DOWN 6.3% YTD
    • Constituent Returns: RXRX (-16.1%); ABSI (-25.9%); ABCL (-32.8%)
    • Reason(s) for Decline:
      • Because of valuation fears across the AI sector, uncertain commercialization timelines for AI‑driven drug pipelines, and heavy cash burn with dilution risk. The sell‑off was part of a broader AI correction, but drug discovery names were hit harder due to their speculative nature and lack of near‑term revenue visibility
    • Article of Interest:
  4. Cannabis MSO Stocks Portfolio: DOWN 23.7% in November; DOWN 4.6% YTD
    • Constituent Returns: GTBIF (-15.9%); CURLF (-19.1%); TCNNF (-25.7%); VRNO (-33.1%); CRLBF (-37.2%)
    • Reason(s) for Decline: 
      • Because of regulatory setbacks in Washington, continued sector‑wide financial struggles, and investor fatigue after years of losses.

The 3 Categories That Declined By At Least 10% in November

  1. Pure-play Cloud Computing Stocks Portfolio: DOWN 12.1%
  2. Pure-play CyberSecurity Stocks Portfolio: DOWN 13.9%​​​​​​​
  3. Pure-play Cryptocurrency ETFs Portfolio: DOWN 19.3%​​​​​​​

The 8 Categories That Declined Less Than 10% in November

  1. Mega-cap Stocks Portfolio: DOWN 0.3%
  2. Pure-play AI Semiconductor Equipment/Material Stocks Portfolio: DOWN 0.6%
  3. Pure-play AI Fabless Semiconductor Stocks Portfolio: DOWN 5.9%
    • ​​​​​​​​​​​​​​​​​​​​​Constituents: NVDA; QCOM; AMD; AVGO; MRVL; MPWR
  4. Pure-play Custom Design Semiconductor Stocks Portfolio: DOWN 7.9% 
    • ​​​​​​​​​​​​​​​​​​​​​Constituents: SNPS; CDNS
  5. Pure-play Critical Mineral Stocks Portfolio: DOWN 8.1%
  6. Cannabis LP Stocks Portfolio: DOWN 8.3%
    • ​​​​​​​​​​​​​​​​​​​​​Constituents: CGC; CRON; ACB; OGI; TLRY
  7. Pure-play Psychedelic Compound-based Stocks Portfolio: DOWN 8.4%
    • ​​​​​​​​​​​​​​​​​​​​​Constituents: ATAI; GHRS; CMPS; MNMD
  8. Pure-play Rare Earth Metal Stocks Portfolio: DOWN 9.6%

The 5 Categories That INCREASED In November

  1. Gold/Silver ETFs Portfolio: UP 16.1%
  2. Pure-play Semiconductor Assembly, Test & Packaging Stocks Portfolio: UP 6.3%
    • ​​​​​​​​​​​​​​​​​​​​​Constituents: ASX; AMKR
  3. Pure-play Semiconductor Foundry Stocks Portfolio: UP 3.3%
    • ​​​​​​​​​​​​​​​​​​​​​Constituents: TSM; TSEM; GFS; UMC
  4. Integrated Device Manufacturer (IDM) Stocks Portfolio: UP 3.2%
    • ​​​​​​​​​​​​​​​​​​​​​Constituents: MU; MCHP; ADI; IFNNY; TXN; NXPI; INTC; STM
  5. Luxury Goods Stocks Portfolio: UP 3.0%​​​​​​​
    • ​​​​​​​​​​​​​​​​​​​​​Constituents: TPR; SIG; CPRI; LVMUY; CFRUY; PPRUY

Summary

On average, the above 20 portfolios were DOWN 4.9% in November.


More By This Author:

All 6 AI Semiconductor Stock Categories Fell Last Week - Here's Why
Pure-Play Quantum Computing Stocks Down 21% Last Week - Here's Why
Worst Day Ever For MSO Cannabis Stocks - Here's Why

This article has been composed with the exclusive application of the human intelligence (HI) of the author. No artificial intelligence (AI) technology has been deployed. 

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.